Healthcare Sales & Marketing Network News: oncolytic virus

Searching News Database: oncolytic virus

HSMN NewsFeed - 17 Jun 2021
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 Mar 2021
Codagenix Expands Senior Management Team With Three New Appointments
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Jan 2021
Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 31 Dec 2020
ImmVira Announces Series C Financing with Leading Specialist Investors
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 7 Dec 2020
KaliVir Immunotherapeutics and Astellas Enter Worldwide Exclusive Licensing Agreement for Development and Commercialization of VET2-L2 Novel Oncolytic Virus
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 20 Jul 2020
FDA Clears Abivertinib for Phase 2 Safety and Efficacy Study in Hospitalized Patients with Moderate To Severe Covid-19
Biopharmaceuticals FDA

HSMN NewsFeed - 19 May 2020
BioEclipse Therapeutics(TM) Announces Move to New Corporate Headquarters in Mountain View, CA
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Mar 2020
Alopexx Oncology Announces Licensing Agreement with Beijing Shenogen Pharma Group for Development and Commercialization of Novel Immunocytokine for the Treatment of B-Cell Lymphomas in China/Asia
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 5 Nov 2019
Regeneron Provides Updates on Phase 3 Libtayo(R) (cemiplimab) Development Program in Advanced Non-small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Sep 2019
Valo Therapeutics Acquires PeptiENV Technology from the University of Helsinki
Biopharmaceuticals Drug Delivery Oncology Acquisitions

HSMN NewsFeed - 24 Jun 2019
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 17 Jun 2019
Valo Therapeutics Appoints Michael Stein as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 May 2019
Calidi Biotherapeutics Announces The Appointment Of Seasoned Biotech Executive Dr. Ashok Srivastava To Their Scientific Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Apr 2019
Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Aug 2018
Oncorus(R), Inc., Names Industry Veteran Ted Ashburn as new President and CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Jul 2018
Adlai Nortye Raises $53M in Series B
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 3 Jul 2018
Sorrento Acquires the Sofusa(TM) Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics
Biopharmaceuticals Oncology Drug Delivery Acquisitions

HSMN NewsFeed - 22 Jun 2018
Replimune Appoints Dieter K. Weinand to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Jun 2018
Replimune Appoints Dr. Hyam I. Levitsky to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 30 Apr 2018
Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin(TM) Cytokines
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 3 Oct 2017
Oncorus(R), Inc., Names Christophe Qu�va, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Sep 2017
Oncolytics Biotech(R) Announces the Presentation of REOLYSIN(R) Clinical Data at ESMO 2017 Congress
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Sep 2017
Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 29 Aug 2017
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 28 Apr 2017
Sorrento Therapeutics Announces Closing of its Acquisition of Virttu Biologics
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 10 Nov 2016
Akriveia Therapeutics Announces Key Additions to its Leadership Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 10 Nov 2016
Oncolytics Biotech(R) Inc. Announces Appointment of New Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 2 Nov 2016
Turnstone Biologics Raises $41.4 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 4 Aug 2016
DNAtrix Awarded FDA Orphan Products Development Grant for DNX-2401
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 17 May 2016
Nouscom Concludes Successful Series A Financing of EUR 12 Million
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 28 Oct 2015
Turnstone Biologics Completes Series A Financing Led by Versant Ventures, Strengthens Management Team
Biopharmaceuticals Oncology Personnel Venture Capital

HSMN NewsFeed - 19 Oct 2015
Virttu Biologics Announces Appointment Of Deirdre Y. Gillespie As Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 24 Sep 2015
Replimune Ltd Raises $30 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 24 Jun 2015
ViraTherapeutics Raises �3.6 Million in the First Closing of a Series A Financing Round to Advance its Novel Oncolytic Virus Platform
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 2 Dec 2014
Oncolytics Biotech(R) Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for Pancreatic and Ovarian Cancers
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Sep 2011
Theracrine Appoints Steven Kelly as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Feb 2011
Jennerex Appoints James M. Burke, M.D. Vice President, Clinical Research
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 9 Feb 2011
Oncos Therapeutics Increases Clinical Momentum With Appointment of Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Jan 2011
Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Sep 2010
Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 May 2010
Neotropix Announces Enrollment of Patients in NCI-Sponsored Phase II Clinical Trial for Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Sep 2008
Neotropix Appoints Anthony Williams, M.D., as Its Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 9 Sep 2008
Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 22 Jul 2008
Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in the American Cancer Society's Journal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Apr 2008
AANS/CNS and BrainLAB Announce Winner of 2008 International Research Fellowship
Neurosurgery

HSMN NewsFeed - 15 Nov 2007
BioVex Closes Second Round of Series E Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Oct 2007
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Sep 2007
BioVex Appoints Dr. Leonard Post to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Aug 2007
BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2007
BioVex Raises $22 Million in First Close of Series E Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Jan 2007
Cell Genesys Announces Encouraging Follow-Up Survival Data From Phase 2 Clinical Trial of GVAX(R) Immunotherapy for Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Dec 2006
ImmunoCellular Therapeutics Announces Dr. Robert Martuza, Chief of Neurosurgery at Mass. General, Joins Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Oct 2006
Cell Genesys Announces Management Change
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 3 Jun 2006
New Data Support the Safety, Activity and Versatility of Introgen's Oncolytic Virus Program
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jun 2006
Cell Genesys Reports Long-Term Follow-Up Data From Phase 2 Trial of GVAX(R) Immunotherapy For Leukemia in Chronic Myelogenous Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 May 2006
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 May 2006
Neotropix Receives FDA Approval to Begin Clinical Trials With First Investigational Cancer Drug
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 13 Mar 2006
Cell Genesys to Present Data From Two GVAX(R) Cancer Immunotherapy Clinical Trials at 2006 ASCO Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Feb 2006
BioVex Inc Begins Dosing Patients in Phase II Clinical Trials of OncoVEXGMCSF in Malignant Melanoma and in Head and Neck Cancer
Biopharmaceuticals Oncology

Return to NewsFeed

Additional items found! 26

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 26 additional stories matching:
oncolytic virus
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.